ReEmerge raises $37M
ReEmerge announced a Series A round of $37M on 15 September 2026. The company operates in HealthTech and is based in United States. It was founded by Todd Langevin, CEO. Announced 43 days ago.
Founder
Todd Langevin
CEO, ReEmerge
Outreach angles
- -Todd Langevin leads ReEmerge as CEO, working alongside physician-scientist co-founder Dr. Nicholas Schiff of Weill Cornell Medicine.
- -The company's technology builds on Schiff's research published in Nature Medicine on neural stimulation for brain injury.
- -The oversubscribed $37M Series A will fund a multicenter clinical study enrolling up to 40 patients with chronic traumatic brain injury.
Signals
Series AHealthcareDeep TechB2BRegulated Industry
Round details
Company: ReEmerge
Domain: reemergeinc.com
Amount: $37M
Stage: Series A
Industry: HealthTech
Country: United States
Announced: 15 September 2026
Other HealthTech raises
Recently funded in United States